Asia · Markets & Finance · Vietnam Investment Review

Kexing Biopharm displays biosimilar pipeline at CPHI Milan

Published by Vietnam Investment Review · Vietnam 15 h ago

Pharmaceutical developer Kexing Biopharm presented its co-developed biosimilar drug pipeline and commercial overseas portfolio at the CPHI Milan 2026 trade exhibition.

Read the full article on Vietnam Investment Review Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading

Tech in Asia

Malaysia’s OutPerform launches AI avatar for developers

Mint

Up 50% in 6 months! Small-cap stock Aye Finance rises today despite weak market - Q2 business update, share price return

The Straits Times Business

MAS introduces enhanced safeguards around public events by financial institutions

CNBC-TV18

Swaraj Engines Q2 Results: Stock jumps 14% after 26% revenue growth, margin expansion

The Economic Times

Why SC cancelled polls in 50 Punjab wards

The Business Times

Kexing Biopharm displays biosimilar pipeline at CPHI Milan

Share

Also worth reading

Malaysia’s OutPerform launches AI avatar for developers

Up 50% in 6 months! Small-cap stock Aye Finance rises today despite weak market - Q2 business update, share price return

MAS introduces enhanced safeguards around public events by financial institutions

Swaraj Engines Q2 Results: Stock jumps 14% after 26% revenue growth, margin expansion

Why SC cancelled polls in 50 Punjab wards

MAS introduces enhanced safeguards around public events by financial institutions